Der var flere patienter i Alpheon- gruppen end i sammenligningsgruppen, som fik tilbagefald af sygdommen efter behandlingens ophør, og Alpheon gav flere bivirkninger.
However, some differences were seen between the two medicines: more patients experienced a return of the disease after treatment with Alpheon was stopped than with the reference medicine, and there were more side effects with Alpheon.